Top Industry Leaders in the Multiple Myeloma Treatment Market
Latest Multiple Myeloma Treatment Companies Updates:
Pfizer Secured conditional approval in the EU for their BCMA-targeted immunotherapy Belantamab maftrumet (BLENFLEXA) for relapsed/refractory multiple myeloma (RRMM).Initiated Phase 3 clinical trials investigating BLENFLEXA in combination with other therapies for earlier treatment settings in multiple myeloma.
Bristol Myers Squibb (US) Reported positive Phase 2 data demonstrating the efficacy and safety of their BCMA-directed CAR-T cell therapy lisocabtagene marocileucel (Cellection) in heavily pretreated patients with RRMM.Received FDA Breakthrough Therapy designation for Cellection in combination with lenalidomide and dexamethasone for treating RRMM.
Janssen Pharmaceuticals (US) Announced promising initial data from their Phase 2 trial evaluating daratumumab monotherapy for the treatment of smoldering multiple myeloma.Partnered with academic institutions to investigate new treatment strategies involving CAR-T cell therapy and bispecific T-cell engagers for multiple myeloma.
AbbVie Inc. (US) Received FDA fast track designation for their investigational BCMA-targeted antibody-drug conjugate, eltanahtib, for treating RRMM.Collaborated with patient advocacy groups to expand access to clinical trials and support patients with multiple myeloma.
The Multiple Myeloma Research Foundation (MMRF) Launched a new research initiative focusing on identifying and targeting drug resistance mechanisms in multiple myeloma.Funded clinical trials investigating promising new therapies and personalized treatment approaches for multiple myeloma patients.
List of Multiple Myeloma Treatment Key companies in the market
- Celgene Corporation
- Janssen Biotech, Inc.
- Bristol-Myers Squibb Company
- Novartis AG
- Millennium Pharmaceuticals
- Amgen, Inc.
- Genzyme Corporation
- Juno Therapeutics
- Johnson & Johnson
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- AbbVie Inc.
- Novartis AG
- Innate Pharma SA
- Celldex Therapeutics, Inc.
- Onyx Pharmaceuticals
- Pfizer
- Takeda Pharmaceuticals